- PRO
- Database
- Screener
- ETF Tools
- News
- ETF Research
- Advisors
- AI ETFs
- Blockchain ETFs
- ESG InvestingNEW
- MediaNEW
| Type | Ticker | Expense Ratio | Assets | Avg. Daily Vol | YTD Return |
|---|---|---|---|---|---|
| Cheapest | |||||
| Largest (AUM) | |||||
| Most Liquid (Volume) | |||||
| Top YTD Performer | |||||
This ETF focuses in on an interesting and often forgotten segment of the health care industry, the medical device makers. Companies in this segment tend to have more stable revenue streams, less issues with patent pipelines, and are often much smaller than their counterparts in big pharma. As a result of their size, many of the companies in IHI are found in very small quantities in large diversified health care ETFs such as XLV making IHI an interesting play to 'complete' exposure to the industry. However, while the industry may not have the same patent issues as pharma or the volatility of the biotech industry, it does have incredibly high levels of competition. This is because any commodity type products are easy to replicate while any patented products are often not crucial to a hospital and instead just make life a lot easier or more efficient for medical personnel, making these goods more 'luxury' in nature. Overall, IHI offers a nice mix of exposure in the industry and could be an excellent choice for investors who already are heavy in holdings to the pharma or broad health care industry but are still looking to round out overall exposure.
The adjacent table gives investors an individual Realtime Rating for IHI on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a . To view information on how the ETFdb Realtime Ratings work, click here.
View the Category ReportA+ Overall Rated ETF:
| Metric | Metric Realtime Rating | A+ Metric Rated ETF |
|---|---|---|
| Liquidity | B+ | n/a |
| Expenses | B+ | n/a |
| Performance | ||
| Volatility | ||
| Dividend | ||
| Concentration |
The following tables and charts contain in-depth metrics for this ETF and compare it to similar peer ETFs within its kendrawilkinson.info Category.
This section compares how balanced and deep this ETF is relative to the peer group kendrawilkinson.info Category.
| Asset | Percentage |
|---|---|
| Common equity | 99.86% |
| ETF Cash Component | 0.14% |
| Sector | Percentage |
|---|---|
| Healthcare | 94.3% |
| Industrials | 5.56% |
| ETF Cash Component | 0.14% |
| Market Cap | Percentage |
|---|---|
| Large cap | 70.12% |
| Mid cap | 16.73% |
| Small cap | 6.97% |
| Micro cap | 6.04% |
| ETF Cash Component | 0.14% |
| Region | Percentage |
|---|---|
| North America | 99.44% |
| Europe | 0.56% |
| Region | Percentage |
|---|---|
| United States | 99.44% |
| Developed Markets (ex-US) | 0.56% |
| Country | Percentage |
|---|---|
| United States | 99.44% |
| United Kingdom | 0.56% |
This section compares the cost efficiency of this ETF to peers in the same kendrawilkinson.info Category.
This ETF is not currently available for commission free trading on any platforms.
There are 4 other ETFs in the Health & Biotech Equities kendrawilkinson.info Category that are also eligible for commission free trading:
This section shows how this ETF has performed relative to its peer group kendrawilkinson.info Category.
This section compares the fund flows of this ETF to peers in the same kendrawilkinson.info Category.
The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.
The following chart also includes the option to compare the performance of IHI relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.
This section shows how the P/E multiple of this ETF compares to the peer group kendrawilkinson.info Category.
This section shows how the dividend yield of this ETF compares to the peer group kendrawilkinson.info Category.
This section shows how the volatility of this ETF compares to the peer group kendrawilkinson.info Category.
Fact sheets are issued by the ETF provider and framed by kendrawilkinson.info. Information contained within the fact sheet is not guaranteed to be timely or accurate.
Below is a look at ETFs that currently offer attractive buying opportunities.
The ETFs included...
Here is a look at ETFs that currently offer attractive short selling opportunities.
The ETFs...
Here is a look at ETFs that currently offer attractive income opportunities. The high-yield...
Smart beta exchange-traded funds (ETFs) have become increasingly popular over the past several years. In fact, BlackRock projects that smart beta ETFs will grow at a 20% annual pace to $1 trillion in assets under management by 2020.
Smart beta exchange-traded funds (ETFs) have become a popular way for investors to target specific portfolio outcomes like reduced risk, enhanced returns or higher income at a lower cost than actively managed funds.
With the rise of bonds ETFs investors now have more ways than ever before to improve, as well as damage, their fixed income portfolios.